Skip to the answer

Propranolol (Infantile Hemangioma)

Propranolol is a beta-blocker given intravenously to treat serious heart rhythm problems, including dangerous arrhythmias that haven't responded to other treatments.

Brand names HemangeolInderalInnoPran
Drug class Beta-adrenergic Blocker
Rx
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026 Content updated Oct 5, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

✓No current FDA shortage listed · checked Oct 5, 2026
Dr. Brian Staiger, PharmD, BCPS
The Pharmacist’s Take By · Clinical pharmacist · Written

This is the intravenous (IV) form of propranolol, one of the oldest and most familiar beta-blockers, given only in the hospital to bring serious, too-fast heart rhythms under control by blocking adrenaline’s signals on the heart, airways and blood vessels. It works fast and strongly, so a slow heart rate, low blood pressure and lightheadedness are common, which is why heart rhythm and blood pressure are monitored throughout. Watch for wheezing or breathlessness, since it can tighten the airways in asthma, and for worsening heart failure. It can also hide the early warning signs of low blood sugar, especially in children and people with diabetes.

Clinical pearls

  • Children fasting before surgery are at higher risk of low blood sugar, so ask how sugar checks will be handled.
  • Tell the team about any digoxin use, because the two together can slow the heart rate dangerously.
  • If epinephrine (adrenaline) is given alongside propranolol, blood pressure can climb out of control, so flag it for every clinician.
  • With an overactive thyroid, propranolol should never be stopped suddenly, since that can trigger a dangerous thyroid storm.
How we write & review this content — our editorial policy →
How you get itPrescription only
Earliest FDA record1967
FDA label last updatedJun 22, 2026
FDA’s strongest warning (boxed)None on the label

Patient information guide A plain-language walkthrough of Propranolol (Infantile Hemangioma), written from its FDA label.

What Propranolol (Infantile Hemangioma) is used for

▾

IV propranolol is used in hospitals to treat serious, life-threatening heart rhythm problems. Main uses include:

  • Supraventricular tachycardia (SVT) — abnormally fast rhythms starting in the upper chambers of the heart, including Wolff-Parkinson-White syndrome and thyrotoxicosis-related fast heart rate
  • Ventricular tachycardia — fast rhythms in the lower chambers, when other treatments haven't worked
  • Digitalis toxicity arrhythmias — dangerous rhythms caused by too much digitalis in the body
  • Anesthesia-related tachyarrhythmias — fast rhythms triggered by excess stress hormones released during surgery, when other measures have failed

How Propranolol (Infantile Hemangioma) works

▾

Propranolol is a nonselective beta-blocker, meaning it blocks both beta-1 receptors (mainly in the heart) and beta-2 receptors (in the lungs, blood vessels, and other smooth muscle). Blocking the heart's beta-1 receptors slows down both the heart rate and the speed of electrical signals through the heart's conduction system — including the AV node. This helps rein in dangerously fast or irregular rhythms.

Because it also blocks beta-2 receptors, it can tighten the airways in the lungs — which is why it's dangerous in people with asthma or chronic lung disease. At higher doses, it also has a separate stabilizing effect on the heart's electrical signals, similar to a membrane-stabilizing agent, though this effect's role in treating arrhythmias isn't fully established.

Propranolol (Infantile Hemangioma) dosage

▾

This form of propranolol is given as a slow IV injection in a hospital — never taken at home. It is administered under constant monitoring of heart rhythm and blood pressure.

  • It is injected slowly — the rate is carefully controlled to reduce the risk of dangerous drops in blood pressure or heart stoppage
  • A second dose may be given a couple of minutes after the first if needed; after that, at least four hours must pass before any additional doses
  • Dosing stops as soon as the desired change in heart rate or rhythm is achieved
  • The goal is to transition to an oral form of propranolol as soon as safely possible

Dosing details from the FDA-approved label

From the Propranolol (Infantile Hemangioma) prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.

The usual dose is 1 mg to 3 mg administered under careful monitoring, such as electrocardiographiy and central venous pressure.

Read the label’s full dosing text

The usual dose is 1 mg to 3 mg administered under careful monitoring, such as electrocardiographiy and central venous pressure. The rate of administration should not exceed 1 mg (1 mL) per minute to diminish the possibility of lowering blood pressure and causing cardiac standstill. Sufficient time should be allowed for the drug to reach the site of action even when a slow circulation is present. If necessary, a second dose may be given after two minutes. Thereafter, additional drug should not be given in less than four hours. Additional propranolol hydrochloride should not be given when the desired alteration in rate and/or rhythm is achieved. Transfer to oral therapy as soon as possible. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

Read the full Dosage and Administration section on DailyMed →

Propranolol (Infantile Hemangioma) side effects

▾

The most common side effects with IV propranolol involve the heart and circulation:

Common side effects

  • Low blood pressure (hypotension)
  • Slow heart rate (bradycardia)
  • Nausea
  • Lightheadedness
  • Fatigue or weakness
  • Worsening heart failure
  • Shortness of breath (dyspnea)
  • Shortness of breath or bronchospasm, especially in people with lung conditions

When to get medical help

  • Signs of very low blood pressure: dizziness, fainting, extreme weakness
  • Dangerously slow heart rate or worsening heart block
  • Difficulty breathing or wheezing — especially in people with asthma or lung disease
  • Signs of low blood sugar (hypoglycemia): shakiness, confusion, sweating — especially in children or diabetic patients
  • Worsening heart failure: sudden weight gain, swelling, severe shortness of breath
  • Signs of a serious allergic reaction: rash, throat swelling, difficulty breathing
  • Cardiac arrest — reported in post-marketing use

Seek immediate medical attention for signs of severely slowed heart rate, difficulty breathing, fainting, or chest tightness — these require urgent evaluation.

Propranolol (Infantile Hemangioma) warnings and precautions

▾
  • Heart failure: Propranolol can worsen heart failure by reducing the heart's pumping strength. It should be avoided in patients with active, decompensated heart failure.
  • Asthma and lung disease: Propranolol can cause dangerous airway tightening (bronchospasm). It is contraindicated in asthma and must be used with extreme caution in any chronic lung disease.
  • Low blood sugar (hypoglycemia): Propranolol masks the usual warning signs — like a fast pulse — that signal low blood sugar. This is especially dangerous in children and insulin-dependent diabetics, particularly when fasting.
  • Thyroid disease: It can hide signs of an overactive thyroid. Stopping it suddenly can trigger thyroid storm — a dangerous surge of thyroid hormone activity.
  • Major surgery: Tell your surgical team if you are on propranolol, since it limits how the heart responds to stress during anesthesia and can increase the risk of dangerously low blood pressure.

Propranolol (Infantile Hemangioma) interactions

▾

Several drugs and substances can interact seriously with IV propranolol:

  • Digitalis (digoxin): Propranolol does not cancel digitalis's heart effects — together they can cause an extremely slow heart rate or complete heart block
  • Epinephrine (adrenaline): Can cause uncontrolled, dangerous high blood pressure when given alongside propranolol
  • Dobutamine / isoproterenol: Can reverse propranolol's effects, but the combination may cause severe, prolonged low blood pressure
  • Insulin and diabetes medications: Propranolol can hide the early physical warning signs of low blood sugar, making it harder to detect a hypoglycemic episode
  • General anesthetics (inhaled): All inhaled anesthetics depress heart function on their own; combining with propranolol increases that risk and demands close monitoring
  • Aminophylline / isoproterenol: May be used to counteract bronchospasm caused by propranolol overdose or excessive effect

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

🌿236 supplements and herbs with documented Propranolol (Infantile Hemangioma) interactions, ranked by severity Check Propranolol (Infantile Hemangioma) against a supplement or herb →

Before taking Propranolol (Infantile Hemangioma)

▾
  • Cardiogenic shock: Must not be used — the heart is too weak to tolerate further reduction in pumping function
  • Sinus bradycardia or significant heart block: Must not be used — propranolol slows the heart further and can be life-threatening
  • Bronchial asthma: Contraindicated — can trigger severe, life-threatening bronchospasm
  • Allergy to propranolol: Must not be used
  • Chronic lung disease (emphysema, chronic bronchitis): Use only with extreme caution; airway tightening is a real risk
  • Diabetes (especially insulin-dependent): Propranolol masks low blood sugar warning signs; requires close glucose monitoring
  • Children: At higher risk for low blood sugar, especially when fasting before a procedure
  • Thyroid disease: Masking of symptoms can delay diagnosis; stopping suddenly can trigger thyroid storm
  • Kidney problems or prolonged exertion: Associated with increased risk of hypoglycemia

Propranolol (Infantile Hemangioma) overdose

▾

Too much propranolol can cause dangerously low blood pressure and a very slow heart rate. Serious cases may need temporary heart pacing, and medications like glucagon, isoproterenol, or dopamine may be used to support the heart. Propranolol is not significantly removed by dialysis, so management focuses on supportive care and close monitoring of heart rhythm, blood pressure, and blood sugar.

What Propranolol (Infantile Hemangioma) does in the body

▾

By blocking beta-1 receptors in the heart, propranolol slows the heart rate, reduces the force of each contraction, and slows electrical conduction through the AV node — the heart's main electrical relay. These combined effects help control or terminate abnormal fast rhythms. By also blocking beta-2 receptors, it causes tightening of smooth muscle in the airways and blood vessels, which is why it must be used cautiously in people with lung disease.

How your body processes Propranolol (Infantile Hemangioma)

▾

After IV administration, propranolol distributes rapidly into tissues — its distribution half-life (how quickly it spreads from the blood into the body) is just 5 to 10 minutes. About 90% of the drug in the bloodstream is bound to plasma proteins, which affects how it acts. The elimination half-life — the time it takes for the body to clear half the drug — ranges from about 2 to 5.5 hours. The drug is processed (metabolized) in the body, and its active beta-blocking effects come specifically from its S(-) form.

How to store Propranolol (Infantile Hemangioma)

▾

Store at 20° to 25°C (68° to 77°F) . Protect from freezing and excessive heat.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

236

Supplements & herbs that interact with Propranolol (Infantile Hemangioma)

236 supplements and herbal products have documented interactions with Propranolol (Infantile Hemangioma) in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 5
  • Moderate · 194
  • Minor · 37
ACTIVATED CHARCOAL Major AMERICAN HELLEBORE Major AMERICAN MISTLETOE Major INDIAN SNAKEROOT Major TYRAMINE Major 1,3-DMAA Moderate ACACIA RIGIDULA Moderate ACTIVE HEXOSE CORRELATED COMPOUND (AHCC) Moderate +228 more
Every supplement checked against Propranolol (Infantile Hemangioma) — ranked by severity The full interaction hub: 5 major · 194 moderate · 37 minor · every one linked to its full report. Check Propranolol (Infantile Hemangioma) against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

1

Nutrient depletion considerations

Propranolol (Infantile Hemangioma) has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

COENZYME Q10 Insufficient Evidence
See the full Propranolol (Infantile Hemangioma) nutrient depletion report

Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.

Propranolol (Infantile Hemangioma): pharmacist answers to common questions

Quick, plain-English answers to the questions patients ask most about Propranolol (Infantile Hemangioma) — the kind of thing our pharmacy team would talk through with you at the counter.

Why is my child receiving propranolol through an IV instead of a pill?

▾
The IV form is reserved for serious heart rhythm emergencies where a fast response is needed — situations where there's no time to wait for a pill to be absorbed. It's given in a hospital so the heart can be monitored continuously. Once things stabilize, the goal is to switch to an oral form as quickly as possible.

What are the most important side effects to watch for while someone is on this IV medication?

▾
The main ones to know about are a very slow heart rate, a significant drop in blood pressure, and difficulty breathing or wheezing — especially in anyone with asthma or lung disease. In children, low blood sugar is also a real risk, particularly if they've been fasting. The medical team will be monitoring for all of these continuously while the medication is being given.

My child has asthma — is this medication safe for them?

▾
This is a very important concern. Propranolol is actually contraindicated — meaning it should not be used — in people with bronchial asthma, because it can cause dangerous tightening of the airways. If your child has asthma, their care team needs to know this before this medication is given. Make sure you've told every doctor involved in their care.

My child is diabetic. Does propranolol affect their blood sugar?

▾
Yes, and this is something to watch closely. Propranolol can mask the usual early warning signs of low blood sugar — like a racing heartbeat — making it harder to catch a hypoglycemic episode before it becomes serious. This is especially true in children who are fasting before a procedure. The care team will monitor blood sugar carefully, but you should let them know about any diabetes management your child is on.

Can anything reverse propranolol's effects if something goes wrong?

▾
Yes. In the event of an overdose or an excessive response, medications like glucagon, isoproterenol, or dopamine can be used to support the heart. If bronchospasm occurs, aminophylline or isoproterenol may help. That said, propranolol is not removed by dialysis, so the team focuses on careful supportive management and close monitoring.

Will propranolol interact with other medications my child or family member is already taking?

▾
It can, yes. The most important interactions are with digitalis (which together with propranolol can cause an extremely slow heart rate), insulin (propranolol hides the warning signs of low blood sugar), and epinephrine (which can cause dangerously high blood pressure when combined with propranolol). Make sure the hospital team has a complete list of every medication, supplement, or treatment being used.

Is Propranolol (Infantile Hemangioma) available over the counter?

▾
No. Propranolol (Infantile Hemangioma) is a prescription medicine: every Propranolol (Infantile Hemangioma) product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was Propranolol (Infantile Hemangioma) first available?

▾
The earliest FDA record we hold for Propranolol (Infantile Hemangioma) is from 1967: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when Propranolol (Infantile Hemangioma) was first used.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →

More about Propranolol (Infantile Hemangioma) on HelloPharmacist

📊Propranolol (Infantile Hemangioma) supplement interactions236 checked — ranked by severity 🌿Drug & Supplement CheckerPropranolol (Infantile Hemangioma) vs. vitamins & herbs 💬Ask a PharmacistFree answer, usually < 24h 🔎NDC & pricing lookupFind Propranolol (Infantile Hemangioma) NDCs & costs 🅰️Browse Drugs A–ZLook up any medication
Detailed data & references for Propranolol (Infantile Hemangioma) Forms & strengths, pricing, billing codes, manufacturers, safety reports and sourcing — the data behind the page. Most people can stop here. Each section below opens on a tap.

Propranolol (Infantile Hemangioma) on the U.S. market: products, makers and brands

How Propranolol (Infantile Hemangioma) appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

The FDA lists Propranolol (Infantile Hemangioma) products; the earliest marketing or approval year on record is 1967. Brand names on the directory include Hemangeol, Inderal, InnoPran; the rest are generics.

1967
Earliest FDA record ⓘ

How widely Propranolol (Infantile Hemangioma) is used (Medicaid data)

A general measure of how commonly Propranolol (Infantile Hemangioma) is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Propranolol (Infantile Hemangioma) is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

2,801,185
Medicaid prescriptions filled (Q1–Q4 2025)
$48.3M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Propranolol (Infantile Hemangioma) prescribed? Of the 1,601 medications we measure, Propranolol (Infantile Hemangioma) ranks #79 by Medicaid prescriptions — more than 95% of them.

Where Propranolol (Infantile Hemangioma) ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5
Total prescriptions — #79 of 1,601
#74 Clindamycin 3,018,439 Rx #75 Hydrocortisone Topical 2,941,220 Rx #76 Mupirocin 2,929,179 Rx #77 Empagliflozin 2,905,773 Rx #78 Venlafaxine 2,819,501 Rx #79 Propranolol (Infantile... 2,801,185 Rx #80 Propranolol (Cardiovas... 2,801,185 Rx #81 Propranolol 2,801,185 Rx #82 Alprazolam 2,797,728 Rx #83 Topiramate 2,782,995 Rx #84 Furosemide 2,765,096 Rx

Utilization by Propranolol (Infantile Hemangioma) product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 10 mg oral tablet is the most-dispensed Propranolol (Infantile Hemangioma) product — about 42% of these Medicaid prescriptions.

propranolol hydrochloride 10 MG Oral Tablet Most dispensed

1,186,622 Medicaid prescriptions (Q1–Q4 2025) 42% of Propranolol (Infantile Hemangioma) prescriptions shown $14.3M gross reimbursement (before rebates) ≈ $12 per prescription (gross)

Summed across the 14 of 132 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856448

propranolol hydrochloride 20 MG Oral Tablet

790,550 Medicaid prescriptions (Q1–Q4 2025) 28% of Propranolol (Infantile Hemangioma) prescriptions shown $10.3M gross reimbursement (before rebates) ≈ $13 per prescription (gross)

Summed across the 13 of 153 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856457

propranolol hydrochloride 40 MG Oral Tablet

244,099 Medicaid prescriptions (Q1–Q4 2025) 9% of Propranolol (Infantile Hemangioma) prescriptions shown $3.8M gross reimbursement (before rebates) ≈ $16 per prescription (gross)

Summed across the 12 of 97 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856519

24 HR propranolol hydrochloride 60 MG Extended Release Oral Capsule

231,994 Medicaid prescriptions (Q1–Q4 2025) 8% of Propranolol (Infantile Hemangioma) prescriptions shown $4.2M gross reimbursement (before rebates) ≈ $18 per prescription (gross)

Summed across the 7 of 49 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856535

24 HR propranolol hydrochloride 80 MG Extended Release Oral Capsule

121,733 Medicaid prescriptions (Q1–Q4 2025) 4% of Propranolol (Infantile Hemangioma) prescriptions shown $2.8M gross reimbursement (before rebates) ≈ $23 per prescription (gross)

Summed across the 7 of 37 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856569

24 HR propranolol hydrochloride 120 MG Extended Release Oral Capsule

63,768 Medicaid prescriptions (Q1–Q4 2025) 2% of Propranolol (Infantile Hemangioma) prescriptions shown $1.4M gross reimbursement (before rebates) ≈ $22 per prescription (gross)

Summed across the 4 of 36 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856460

propranolol hydrochloride 60 MG Oral Tablet

50,166 Medicaid prescriptions (Q1–Q4 2025) 2% of Propranolol (Infantile Hemangioma) prescriptions shown $1.2M gross reimbursement (before rebates) ≈ $24 per prescription (gross)

Summed across the 4 of 24 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856556

propranolol hydrochloride 4 MG/ML Oral Solution

40,705 Medicaid prescriptions (Q1–Q4 2025) 1% of Propranolol (Infantile Hemangioma) prescriptions shown $969,403 gross reimbursement (before rebates) ≈ $24 per prescription (gross)

Summed across the 1 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856724

propranolol hydrochloride 80 MG Oral Tablet

36,706 Medicaid prescriptions (Q1–Q4 2025) 1% of Propranolol (Infantile Hemangioma) prescriptions shown $831,940 gross reimbursement (before rebates) ≈ $23 per prescription (gross)

Summed across the 9 of 47 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856578

24 HR propranolol hydrochloride 160 MG Extended Release Oral Capsule

22,201 Medicaid prescriptions (Q1–Q4 2025) <1% of Propranolol (Infantile Hemangioma) prescriptions shown $642,776 gross reimbursement (before rebates) ≈ $29 per prescription (gross)

Summed across the 3 of 17 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856481

propranolol hydrochloride 4.28 MG/ML Oral Solution

9,979 Medicaid prescriptions (Q1–Q4 2025) <1% of Propranolol (Infantile Hemangioma) prescriptions shown $7.8M gross reimbursement (before rebates) ≈ $779 per prescription (gross)

Summed across the 1 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1495058

propranolol hydrochloride 8 MG/ML Oral Solution

2,662 Medicaid prescriptions (Q1–Q4 2025) <1% of Propranolol (Infantile Hemangioma) prescriptions shown $61,495 gross reimbursement (before rebates) ≈ $23 per prescription (gross)

Summed across the 1 of 1 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 856733

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Propranolol (Infantile Hemangioma), and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 76 of 603 listed Propranolol (Infantile Hemangioma) NDCs with Medicaid activity.

Propranolol (Infantile Hemangioma) recall history

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list one Propranolol recall since July 2021. It is no longer listed as ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.

Class II Jan 26, 2022 · Terminated · CARDINAL HEALTHCARE
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
  • Propranolol Hydrochloride Tablets, 20 mg, 100 Tablets per bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Brid… Lots: Batch 100023596 FDA record D-0194-2024 →

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Propranolol (Infantile Hemangioma) RxCUI 8787 5 dose forms · 21 strengths
  3. Dose form (SCDF) Oral Capsule RxCUI 393497 No current FDA listing
    Clinical drug / strength (SCD) hydrochloride 80 MG RxCUI 856735
  4. Dose form (SCDF) Oral Solution RxCUI 373653 No current FDA listing
    Clinical drug / strength (SCD) hydrochloride 1 MG/ML RxCUI 856704 hydrochloride 10 MG/ML RxCUI 856703 hydrochloride 16 MG/ML RxCUI 856712 hydrochloride 2 MG/ML RxCUI 856719 hydrochloride 4 MG/ML RxCUI 856724 hydrochloride 4.28 MG/ML RxCUI 1495058 hydrochloride 8 MG/ML RxCUI 856733 hydrochloride 80 MG/ML RxCUI 856737

Look up RxCUI 8787 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

Propranolol (Infantile Hemangioma) brand names

Propranolol (Infantile Hemangioma) is sold under 3 brand names in the FDA directory — Hemangeol, Inderal, InnoPran. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Hemangeol Inderal InnoPran

Propranolol (Infantile Hemangioma) drug class (RxNorm)

Propranolol (Infantile Hemangioma) belongs to the beta-Adrenergic Blocker class.

Pharmacologic class beta-Adrenergic Blocker
Drug family (ATC) Beta blocking agents, non-selective
How it works Adrenergic beta-Antagonists

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

Sources for this Propranolol (Infantile Hemangioma) page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Jun 22, 2026
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Propranolol (Infantile Hemangioma).
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Propranolol (Infantile Hemangioma) after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
1
Linked representative label ⓘ
HF Acquisition Co LLC, DBA HealthFirst
Linked label effective
Jun 22, 2026
Composite sections available
10
Linked SPL Set ID
54dd0fad-64ee-788f-e063-6394a90ac88e
Linked SPL Document ID
54dd0fad-64ef-788f-e063-6394a90ac88e
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. HF Acquisition Co LLC, DBA HealthFirst is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →